Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Qualgen, LLC
483
•Qualgen, LLC•August 19, 2025

Qualgen, LLC – FDA 483, Aug 19, 2025

Record Details

An FDA inspection conducted at Qualgen, LLC, an outsourcing facility in Edmond, OK, from August 19, 2025, to September 4, 2025, identified significant deviations from established Good Manufacturing Practices. The primary observations included inadequate controls to prevent cross-contamination and widespread failures within the company"s quality control unit.

Specifically, the inspection noted insufficient physical and spatial separation during the manufacturing of hazardous drugs like testosterone and estradiol pellets. Shared anterooms lacked proper cleaning between different product runs, and the effectiveness of cleaning agents and procedures for deactivating hazardous drug residues was not documented. Furthermore, critical equipment used in hazardous drug production was not cleaned according to the company"s own procedures.

A repeat observation highlighted systemic failures within Qualgen"s quality control unit to consistently follow written procedures. This encompassed inaccurate and non-contemporaneous documentation of cleaning activities, deviations from established post-production vial inspection times and signatory requirements, and improper calibration of critical manufacturing equipment such as digital calipers and balances. The firm also failed to investigate and follow up on customer complaints regarding product quality and potential adverse events. Additionally, work instructions for potency testing of Active Pharmaceutical Ingredients were not fully followed, including incorrect preparation of reference standard calibration curves.

Qualgen, LLC is required to implement comprehensive corrective and preventive actions to address these deficiencies, ensuring compliance with regulatory standards and safeguarding the quality and purity of its drug products.

Company
Qualgen, LLC
Inspection date
August 19, 2025
Product type
drugs
Office
Dallas District Office
People
  • Logan T. Williams (Investigator )
  • Zachary L. Stamm (Pharmaceutical Program Expert)
View Company Profile

ID · 7764f418-76a6-42b3-9cc7-ed20bd6671e9

Other documents for Qualgen, LLC
  • 483 - 2024-03-19March 19, 2024
  • 483 - 2022-09-30September 30, 2022
  • 483 - 2017-05-10May 10, 2017
  • 483 - 2015-09-17September 17, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Qualgen, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.